Sawai Pharmaceutical Co Ltd (4555) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- GDPH81802D
- Pages: 36
- November 2018
- Total Views:1123
- Region : Asia
- GlobalData
- Equity Research Report
Details
Summary
Sawai Pharmaceutical Co Ltd (Sawai Pharmaceutical) manufactures, sells, imports and exports ethical drugs and proprietary drugs. The company's products include cardiovascular drugs, antihyperlipidemic agents, diabetes drugs, anticancer drugs, and OTC drugs. It provides products in the form of tablets, oral dispersing tablets, capsules, granule, injection, tape, ophthalmic and nasal solution, and syrup. Sawai Pharmaceutical caters to hospitals, general practitioners and dispensing pharmacies. The company has manufacturing facilities in Kanto, Osaka, Sanda and Kyusyu. It has its presence in Sapporo, Sendai, Kitakanto, Tokyo Daiichi, Tokyo Daini, Nagoya, Osaka, Hiroshima and Fukuoka. Sawai Pharmaceutical is headquartered in Osaka, Japan.
Sawai Pharmaceutical Co Ltd (4555)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table Of Content
Scope
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Upsher-Smith Labs Acquires 20 US Generic Products from Sandoz 12
Sawai Pharma to Acquire Kashima Plant from Mitsubishi Tanabe Pharma Factory for USD39.3 Million 13
Partnerships 14
Upsher-Smith Enters into Marketing and Distribution Agreement 14
Sawai Pharmaceutical Enters Into Manufacturing And Marketing Agreement with AstraZeneca 15
Upsher-Smith Labs Enters into Agreement 16
Upsher-Smith Labs Enters into Agreement with Bluepharma Industria Farmaceutica 17
Upsher-Smith Labs Enters into Agreement with Pharmathen 18
Upsher-Smith Laboratories Enters into Agreement with pharmaceutical company 19
Upsher-Smith Labs Enters Into Development Agreement With Lundbeck 20
Equity Offering 21
Sawai Pharma to Raise USD37.7 Million in Private Placement of Shares 21
Asset Transactions 22
Vertical Pharma Acquires Portfolio Of Womens Health Products From Upsher-Smith Labs 22
Acquisition 24
Sawai Pharma Sells 20% stake in Upsher-Smith Lab for USD211 Million 24
Sumitomo Corporation of America to Acquire 20% Stake in Sawai America for USD211 Million 25
Sawai Pharma Acquires Generic Pharmaceuticals Business of Upsher-Smith Labs from Acova for USD1.05 Billion 26
Upsher-Smith Completes Acquisition Of Remaining 84% Stake In Proximagen For Up To USD 555 Million 28
Sawai Pharmaceutical Co Ltd-Key Competitors 30
Sawai Pharmaceutical Co Ltd-Key Employees 31
Sawai Pharmaceutical Co Ltd-Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Recent Developments 33
Corporate Communications 33
May 15, 2018: Sawai Pharmaceutical Announce Personnel Changes 33
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36
List Of Figure
List of Figures
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
List Of Table
List of Tables
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sawai Pharmaceutical Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Upsher-Smith Labs Acquires 20 US Generic Products from Sandoz 12
Sawai Pharma to Acquire Kashima Plant from Mitsubishi Tanabe Pharma Factory for USD39.3 Million 13
Upsher-Smith Enters into Marketing and Distribution Agreement 14
Sawai Pharmaceutical Enters Into Manufacturing And Marketing Agreement with AstraZeneca 15
Upsher-Smith Labs Enters into Agreement 16
Upsher-Smith Labs Enters into Agreement with Bluepharma Industria Farmaceutica 17
Upsher-Smith Labs Enters into Agreement with Pharmathen 18
Upsher-Smith Laboratories Enters into Agreement with pharmaceutical company 19
Upsher-Smith Labs Enters Into Development Agreement With Lundbeck 20
Sawai Pharma to Raise USD37.7 Million in Private Placement of Shares 21
Vertical Pharma Acquires Portfolio Of Womens Health Products From Upsher-Smith Labs 22
Sawai Pharma Sells 20% stake in Upsher-Smith Lab for USD211 Million 24
Sumitomo Corporation of America to Acquire 20% Stake in Sawai America for USD211 Million 25
Sawai Pharma Acquires Generic Pharmaceuticals Business of Upsher-Smith Labs from Acova for USD1.05 Billion 26
Upsher-Smith Completes Acquisition Of Remaining 84% Stake In Proximagen For Up To USD 555 Million 28
Sawai Pharmaceutical Co Ltd, Key Competitors 30
Sawai Pharmaceutical Co Ltd, Key Employees 31
Sawai Pharmaceutical Co Ltd, Subsidiaries 32
Licence Rights
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Section Purchase
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products and Companies
Products
Sawai Pharmaceutical Co Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Company Profile
Company Profile Title
Summary
Sawai Pharmaceutical Co Ltd (Sawai Pharmaceutical) manufactures, sells, imports and exports ethical drugs and proprietary drugs. The company's products include cardiovascular drugs, antihyperlipidemic agents, diabetes drugs, anticancer drugs, and OTC drugs. It provides products in the form of tablets, oral dispersing tablets, capsules, granule, injection, tape, ophthalmic and nasal solution, and syrup. Sawai Pharmaceutical caters to hospitals, general practitioners and dispensing pharmacies. The company has manufacturing facilities in Kanto, Osaka, Sanda and Kyusyu. It has its presence in Sapporo, Sendai, Kitakanto, Tokyo Daiichi, Tokyo Daini, Nagoya, Osaka, Hiroshima and Fukuoka. Sawai Pharmaceutical is headquartered in Osaka, Japan.
Sawai Pharmaceutical Co Ltd (4555)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Scope
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Upsher-Smith Labs Acquires 20 US Generic Products from Sandoz 12
Sawai Pharma to Acquire Kashima Plant from Mitsubishi Tanabe Pharma Factory for USD39.3 Million 13
Partnerships 14
Upsher-Smith Enters into Marketing and Distribution Agreement 14
Sawai Pharmaceutical Enters Into Manufacturing And Marketing Agreement with AstraZeneca 15
Upsher-Smith Labs Enters into Agreement 16
Upsher-Smith Labs Enters into Agreement with Bluepharma Industria Farmaceutica 17
Upsher-Smith Labs Enters into Agreement with Pharmathen 18
Upsher-Smith Laboratories Enters into Agreement with pharmaceutical company 19
Upsher-Smith Labs Enters Into Development Agreement With Lundbeck 20
Equity Offering 21
Sawai Pharma to Raise USD37.7 Million in Private Placement of Shares 21
Asset Transactions 22
Vertical Pharma Acquires Portfolio Of Womens Health Products From Upsher-Smith Labs 22
Acquisition 24
Sawai Pharma Sells 20% stake in Upsher-Smith Lab for USD211 Million 24
Sumitomo Corporation of America to Acquire 20% Stake in Sawai America for USD211 Million 25
Sawai Pharma Acquires Generic Pharmaceuticals Business of Upsher-Smith Labs from Acova for USD1.05 Billion 26
Upsher-Smith Completes Acquisition Of Remaining 84% Stake In Proximagen For Up To USD 555 Million 28
Sawai Pharmaceutical Co Ltd-Key Competitors 30
Sawai Pharmaceutical Co Ltd-Key Employees 31
Sawai Pharmaceutical Co Ltd-Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Recent Developments 33
Corporate Communications 33
May 15, 2018: Sawai Pharmaceutical Announce Personnel Changes 33
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36
List Of Figure
List of Figures
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
List Of Table
List of Tables
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sawai Pharmaceutical Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Sawai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Upsher-Smith Labs Acquires 20 US Generic Products from Sandoz 12
Sawai Pharma to Acquire Kashima Plant from Mitsubishi Tanabe Pharma Factory for USD39.3 Million 13
Upsher-Smith Enters into Marketing and Distribution Agreement 14
Sawai Pharmaceutical Enters Into Manufacturing And Marketing Agreement with AstraZeneca 15
Upsher-Smith Labs Enters into Agreement 16
Upsher-Smith Labs Enters into Agreement with Bluepharma Industria Farmaceutica 17
Upsher-Smith Labs Enters into Agreement with Pharmathen 18
Upsher-Smith Laboratories Enters into Agreement with pharmaceutical company 19
Upsher-Smith Labs Enters Into Development Agreement With Lundbeck 20
Sawai Pharma to Raise USD37.7 Million in Private Placement of Shares 21
Vertical Pharma Acquires Portfolio Of Womens Health Products From Upsher-Smith Labs 22
Sawai Pharma Sells 20% stake in Upsher-Smith Lab for USD211 Million 24
Sumitomo Corporation of America to Acquire 20% Stake in Sawai America for USD211 Million 25
Sawai Pharma Acquires Generic Pharmaceuticals Business of Upsher-Smith Labs from Acova for USD1.05 Billion 26
Upsher-Smith Completes Acquisition Of Remaining 84% Stake In Proximagen For Up To USD 555 Million 28
Sawai Pharmaceutical Co Ltd, Key Competitors 30
Sawai Pharmaceutical Co Ltd, Key Employees 31
Sawai Pharmaceutical Co Ltd, Subsidiaries 32
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products
Sawai Pharmaceutical Co Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Ask A Question
Our Team Will Assist You in What You Are Looking For
or 
: +91 98100 26150
: ankurgupta1984
Related Reports
Page 130 | 
December 2020
Page 130 | December 2020
Page 131 | November 2020
Page 95 | November 2020
Page 96 | August 2020